ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,760Medicare Part D Prescriptions Filled, Including Refills

Rank: 74 out of 298

$374K Total Retail Price of All Prescriptions

Rank: 68 out of 298

335 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 335 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 335 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 5,154 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
LEVOTHYROXINE SODIUM 323 232 1 1
LISINOPRIL 305 231 2 4
OMEPRAZOLE 224 173 3 3
SIMVASTATIN 208 156 4 2
TRAMADOL HCL 196 147 5 15
FUROSEMIDE 181 143 6 5
GABAPENTIN 144 74 7 20
METFORMIN HCL 140 92 8 10
ALENDRONATE SODIUM 137 123 9 21
WARFARIN SODIUM 131 117 10 7
METOPROLOL TARTRATE 122 104 11 9
IPRATROPIUM BROMIDE 109 69 12 107
SERTRALINE HCL 109 100 12 19
HYDROCHLOROTHIAZIDE 100 88 14 13
AMLODIPINE BESYLATE 99 88 15 6
POTASSIUM CHLORIDE 95 68 16 11
ATENOLOL 91 77 17 16
POLYETHYLENE GLYCOL 3350 83 71 18 29
METOPROLOL SUCCINATE 82 69 19 12
LOSARTAN POTASSIUM 79 66 20 18
ATORVASTATIN CALCIUM 77 57 21 14
CRESTOR 76 60 22 26
NAMENDA 68 68 23 35
FLUOXETINE HCL 68 54 23 50
NEXIUM 66 15 25 40
PREDNISONE 65 60 26 33
DONEPEZIL HCL 64 64 27 22
FENTANYL 63 56 S2 28 32
LANTUS 61 34 29 53
ADVAIR DISKUS 61 39 29 46
PAROXETINE HCL 60 44 31 48
ZOLPIDEM TARTRATE 59 46 32 25
DILTIAZEM 24HR CD 59 59 32 74
CITALOPRAM HBR 58 56 34 17
SUCRALFATE 56 23 35 104
FLUTICASONE PROPIONATE 56 37 35 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 25, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.